Cisatracurium Besylate
Who holds supplier records for Cisatracurium Besylate? 7 organisations hold a current record for Cisatracurium Besylate: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (1), Spain (1), Netherlands (1), Israel (1) and 2 other countries (2); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Cisatracurium Besylate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/cisatracurium-besylate
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Cisatracurium Besylate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- GLAND PHARMA LTDIndia Company GMP cert on recordActive DMF 22962, 29738 · latest filing Sept 2015
- FARMHISPANIA SASpainCEPActive DMF 24999 · latest filing May 2011
- TAPI NL BVNetherlandsCEPActive DMF 23130 · latest filing Sept 2009
- WAVELENGTH ENTERPRISES LTDIsraelCEP Company GMP cert on recordActive DMF 23554 · latest filing Feb 2010
- CF PHARMA LTDActive DMF 24969 · latest filing Aug 2012
- NAVINTA LLCUnited StatesActive DMF 41604 · latest filing Jun 2025
- CF PHARMA KFT.HungaryCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Cisatracurium Besylate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 6 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| CF PHARMA KFT. Budapest IX | HU | CEP 2021-064 - Rev 03 Cisatracurium besilate | May 2026 | Inspected Jan 2026 Hungary |
| TAPI NL B.V. Amsterdam | NL | CEP 2016-093 - Rev 01 Cisatracurium besilate | Jul 2025 | — |
| WAVELENGTH ENTERPRISES LTD. Petah Tikva | IL | CEP 2023-465 - Rev 01 Cisatracurium besilate, Process B | Oct 2024 | — |
| Farmhispania, S.A. Montmeló | ES | R1-CEP 2016-285 - Rev 00 Cisatracurium besilate | Sept 2022 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (3)
Organisations whose Type II DMFs for Cisatracurium Besylate are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- ON DEMAND PHARMACEUTICALS INCInactive DMF 40593 · filed May 2025
- China · Inactive DMF 25511 · filed Nov 2011
- ALP PHARM BEIJING CO LTDInactive DMF 24033 · filed Jul 2010
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Cisatracurium Besylate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200641).
Chemical identity
- IUPAC name
- benzenesulfonate;5-[3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate
- Canonical SMILES
- C[N@@+]1(CCC2=CC(=C(C=C2[C@H]1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N@+]4(CCC5=CC(=C(C=C5[C@H]4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
- InChIKey
- XXZSQOVSEBAPGS-DONVQRBFSA-L
- Synonyms
- 51 W89, 51-W-89, 51-W89, 51W-89, 51W89, Besilate de cisatracurium, Besilato de cisatracurio, Cisatracurium (as besilate), Cisatracurium besilate, Cisatracurium besylate, Cisatracurium besylate preservative free, Nimbex
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Nondepolarizing Neuromuscular Blocker
- Physiologic effect
- Neuromuscular Nondepolarizing Blockade
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Cisatracurium Besylate?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Cisatracurium Besylate: GLAND PHARMA LTD (India), FARMHISPANIA SA (Spain), TAPI NL BV (Netherlands), WAVELENGTH ENTERPRISES LTD (Israel), CF PHARMA LTD, NAVINTA LLC (United States) and CF PHARMA KFT. (Hungary). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Cisatracurium Besylate Drug Master Files are active?
GLAND PHARMA LTD (DMF 22962, 29738), FARMHISPANIA SA (DMF 24999), TAPI NL BV (DMF 23130), WAVELENGTH ENTERPRISES LTD (DMF 23554), CF PHARMA LTD (DMF 24969) and NAVINTA LLC (DMF 41604). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Cisatracurium Besylate records mean?
3 organisations have only inactive Type II DMFs for Cisatracurium Besylate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Cisatracurium Besylate have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Cisatracurium Besylate on the EDQM register, including CF PHARMA KFT. Budapest IX (HU), TAPI NL B.V. Amsterdam (NL), WAVELENGTH ENTERPRISES LTD. Petah Tikva (IL) and Farmhispania, S.A. Montmeló (ES). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Cisatracurium Besylate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Cisatracurium Besylate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.